Overview
A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease
Status:
Terminated
Terminated
Trial end date:
2010-05-01
2010-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a study to evaluate the safety, tolerability and blood levels of PF-03654746 in subjects will mild to moderate Alzheimer's disease.Phase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:- Probable Alzheimer's disease
- Mini Mental State Examination score 18-26 inclusive
- Aged 55-85
Exclusion Criteria:
- Dementia other than Alzheimer's disease
- Clinically significant cardiovascular disease in the past 6 months prior to screening
- Creatinine clearance <30 mL/min